EFSD, JDRF and Lilly European Programme in Type 1 Diabetes Research

קרןEuropean Foundation for the Study of Diabetes
מדינהEurope
סוגResearch Grants
תאריך אחרון01/07/2016
פקולטהLife Sciences, Medicine
תיאור

EFSD, JDRF and Lilly have established a new programme called EFSD/JDRF/Lilly European Programme in Type 1 Diabetes to encourage new projects aimed at advancing current knowledge in this domain.

This year the Programme would particularly welcome projects in the following areas:

  • Research with potential to increase understanding of the natural history, pathogenesis, and/or heterogeneity of human type 1 diabetes;
  • Pancreatic beta cell biology and potential human beta cell regenerative approaches;
  • Pathophysiology of type 1 diabetes autoimmunity with a focus on potential therapeutic targets and autoantigen-specific immunoregulation of type 1 diabetes;
  • Therapies that slow or stop the progression of type 1 diabetes before symptomatic disease or that preserve beta cell function in new onset type 1 diabetes;
  • Biomaterials for implantable, encapsulated beta cell replacement;
  • Automated closed loop artificial pancreas systems and/or its components; 
  • Novel or repurposed therapies to improve glycaemic and overall metabolic control in type 1 diabetes:
  • Glucose-responsive insulin:
  • Therapies that prevent progression of diabetic kidney or eye disease in type 1 diabetes.

Funding: €100,000 (in special cases up to €400,000)

Duration: no fixed limit (at least 1 year)

קבצים מצורפים
קישורלאתר
עדכון אחרוןעדכון אחרון: 11/04/2016
אוניברסיטת תל אביב עושה כל מאמץ לכבד זכויות יוצרים. אם בבעלותך זכויות יוצרים בתכנים שנמצאים פה ו/או השימוש
שנעשה בתכנים אלה לדעתך מפר זכויות, נא לפנות בהקדם לכתובת שכאן >>